QUINCY WALLIS: Open Payments
NPI 1750090429 · OTTAWA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$350 in 19 payments from 15 companies in 2025. Trend: 2023 $28 · 2024 $262 · 2025 $350
Food & beverage: $350
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Grifols USA, LLC | 1 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
| ABBVIE INC. | 1 | $26 |
| Baxter Healthcare | 1 | $24 |
| ANI Pharmaceuticals, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Viatris Specialty LLC | 1 | $20 |
| Tactile Systems Technology Inc | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: AIRSUPRA, Prolastin-C Liquid, CAPLYTA, VRAYLAR, Hillrom - Vest System Model 205 Acute Care, PURIFIED CORTROPHIN GEL, FASENRA, TRELEGY ELLIPTA.
Industry payments across KS — which companies pay providers there.
